{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:48:24Z","timestamp":1765079304359},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,20]]},"DOI":"10.4103\/0366-6999.178014","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T08:54:22Z","timestamp":1456995262000},"page":"716-722","source":"Crossref","is-referenced-by-count":6,"title":["Estimated Financing Amount Needed for Essential Medicines in China, 2014"],"prefix":"10.1097","volume":"129","author":[{"given":"Wei","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gong-Jie","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiao-Yun","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Syuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210129","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.329.7475.1169","article-title":"The concept of essential medicines: Lessons for rich countries","volume":"329","author":"Hogerzeil","year":"2004","journal-title":"BMJ"},{"key":"R2-13-20210129","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/heapol\/czs108","article-title":"Access to medicines from a health system perspective","volume":"28","author":"Bigdeli","year":"2013","journal-title":"Health Policy Plan"},{"key":"R4-13-20210129","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1016\/S2214-109X(13)70077-9","article-title":"Health-sector reform in China and access to essential medicines","volume":"1","author":"Hogerzeil","year":"2013","journal-title":"Lancet Glob Health"},{"key":"R5-13-20210129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3111\/13696998.2012.751176","article-title":"Essential medicine policy in China: Pros and cons","volume":"16","author":"Hu","year":"2013","journal-title":"J Med Econ"},{"key":"R6-13-20210129","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0140-6736(15)00514-0","article-title":"Essential medicines are still essential","volume":"386","author":"Gray","year":"2015","journal-title":"Lancet"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.178014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:38:29Z","timestamp":1623958709000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201603200-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,20]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.178014","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3,20]]}}}